Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases - PubMed (original) (raw)
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases
J R Siewert et al. Br J Surg. 1996 Aug.
Abstract
A retrospective immunohistological analysis of 100 patients with pT1-3 N0 and pT1-3 N1 gastric adenocarcinoma demonstrated a high frequency of micro-involvement in the removed lymph nodes. The presence of three or more tumour cells in more than 10 per cent of the lymph nodes was of significant prognostic value in the pN0 cases. Multivariate analysis identified micro-involvement as an independent prognostic factor. The results explain why patients benefit from lymphadenectomy even if the removed lymph nodes are not involved by tumour (pN0) in routine histological examination. The frequent occurrence of micro-involvement is a strong argument favouring routine D2 lymph node dissection in gastric cancer surgery in patients with lymph node metastasis.
Comment in
- Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.
Noguchi M. Noguchi M. Br J Surg. 1997 Jul;84(7):1032-3. doi: 10.1002/bjs.1800840745. Br J Surg. 1997. PMID: 9240168 No abstract available.
Similar articles
- [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D, Xu H, Huang J. Sun D, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28226354 Chinese. - Prognostic significance of lymphovascular invasion in node-negative gastric cancer.
Lee JH, Kim MG, Jung MS, Kwon SJ. Lee JH, et al. World J Surg. 2015 Mar;39(3):732-9. doi: 10.1007/s00268-014-2846-y. World J Surg. 2015. PMID: 25376868 - Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P, D'Angelo F, Rossi S, Bellagamba R, Cicchini C, Nigri G, Ercolani G, De Angelis R, Ramacciato G. Aurello P, et al. Am Surg. 2007 Apr;73(4):359-66. Am Surg. 2007. PMID: 17439029 Review. - Lymph node dissection for gastric cancer.
Meyer HJ, Jähne J. Meyer HJ, et al. Semin Surg Oncol. 1999 Sep;17(2):117-24. doi: 10.1002/(sici)1098-2388(199909)17:2<117::aid-ssu6>3.0.co;2-7. Semin Surg Oncol. 1999. PMID: 10449683 Review.
Cited by
- Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis.
Zeng YJ, Zhang CD, Dai DQ. Zeng YJ, et al. World J Gastroenterol. 2015 Feb 7;21(5):1628-35. doi: 10.3748/wjg.v21.i5.1628. World J Gastroenterol. 2015. PMID: 25663783 Free PMC article. Review. - Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.
Bonavina L, Ferrero S, Midolo V, Buffa R, Cesana B, Peracchia A. Bonavina L, et al. J Gastrointest Surg. 1999 Sep-Oct;3(5):468-76. doi: 10.1016/s1091-255x(99)80099-7. J Gastrointest Surg. 1999. PMID: 10482702 - Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues.
Marano L, Carbone L, Poto GE, Restaino V, Piccioni SA, Verre L, Roviello F, Marrelli D. Marano L, et al. Curr Oncol. 2023 Jan 8;30(1):875-896. doi: 10.3390/curroncol30010067. Curr Oncol. 2023. PMID: 36661716 Free PMC article. Review. - Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer.
Kong P, Wu R, Yang C, Geng Q, Liu J, Chen S, Liu X, Ye M, He W, Yang Q, Xia L, Xu D. Kong P, et al. Sci Rep. 2016 Jul 6;6:26313. doi: 10.1038/srep26313. Sci Rep. 2016. PMID: 27381549 Free PMC article. - [Sentinel lymph node mapping in gastric and esophageal carcinomas].
Burian M, Stein HJ, Sendler A, Feith M, Siewert JR. Burian M, et al. Chirurg. 2004 Aug;75(8):756-60. doi: 10.1007/s00104-004-0909-6. Chirurg. 2004. PMID: 15278234 German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous